NCT00420251View on ClinicalTrials.gov

Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 1996

Study Completion Date

July 31, 2006

Conditions
Juvenile Idiopathic ArthritisStill Disease, Juvenile-Onset
Interventions
DRUG

Genotropin

Trial Locations (1)

82152

Center For Rheumatic Diseases in Childhood, Garmisch-Partenkirchen

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Ludwig-Maximilians - University of Munich

OTHER